Literature DB >> 2060390

Subclinical cardiac dysfunction in sarcoidosis.

W J Gibbons1, R D Levy, S Nava, I Malcolm, J M Marin, C Tardif, S Magder, R Lisbona, M G Cosio.   

Abstract

Clinically apparent myocardial disease is infrequent in sarcoidosis. However, autopsy data show myocardial involvement in up to 30 percent of patients. Unexplained exertional symptomatology is a common complaint in patients with sarcoidosis. In this study, we investigated whether abnormal cardiac function might limit exercise performance in patients with sarcoidosis without overt cardiac involvement. We studied exercise responses in 35 patients with sarcoidosis and compared them with 28 untrained controls. Seventy-seven percent of the patients were symptomatic. Pulmonary function test results were lower in the group with sarcoidosis than normal controls, but they were within normal range. Only one patient had evidence of ventilatory limitation to exercise. Sixteen (46 percent) patients had abnormally increased heart rates (HRs) at rest prior to exercise testing and/or with exercise. Rapid HRs were confirmed during daily activities by continuous ambulatory electrocardiographic (ECG) monitoring. Left ventricular ejection fraction (LVEF) was measured to determine if systolic dysfunction could account for abnormal HR responses. Of patients with abnormally increased HRs, five had LVEFs less than 50 percent, and eight had normal LVEFs, of whom 75 percent had tachycardia at rest. Retrospective comparison of HR responses and LVEF between patients who did or did not receive corticosteroids revealed no significant differences between groups. We conclude that abnormal HR responses in patients without evident cardiac sarcoidosis are common and exertional symptoms in this population are often associated with chronotropic abnormalities. The exact mechanisms underlying the chronotropic abnormalities are unclear, but they likely include ventricular systolic dysfunction, sinus node dysfunction from granulomatous infiltration, or combinations of the two.

Entities:  

Mesh:

Year:  1991        PMID: 2060390     DOI: 10.1378/chest.100.1.44

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Sarcoidosis Masquerading as Atrial Fibrillation: Interesting Case Discussion as Well as Recent Advances in Diagnosis and Management of Cardiac Sarcoidosis.

Authors:  Jefferson Curimbaba; João Pimenta; José Marcos Moreira; UlSilvia Carla Sousa Rodrigues; Ester Nei Aparecida Coletta; Carlos A C Pereira
Journal:  J Atr Fibrillation       Date:  2012-12-16

2.  Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis.

Authors:  Agnaldo José Lopes; Sara Lucia Silveira de Menezes; Cristina Márcia Dias; Juliana Flávia de Oliveira; Míriam Raquel Meira Mainenti; Fernando Silva Guimarães
Journal:  Lung       Date:  2011-08-20       Impact factor: 2.584

Review 3.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 4.  Sarcoid heart disease.

Authors:  Simon W Dubrey; Alex Bell; Tarun K Mittal
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

Review 5.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

Review 6.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 7.  Sarcoidosis and the heart: A review of the literature.

Authors:  Emrah Ipek; Selami Demirelli; Emrah Ermis; Sinan Inci
Journal:  Intractable Rare Dis Res       Date:  2015-11

8.  Role of imaging in the detection of reversible cardiomyopathy.

Authors:  Jae-Hyeong Park; Deborah H Kwon; Randall C Starling; Thomas H Marwick
Journal:  J Cardiovasc Ultrasound       Date:  2013-06-26

9.  Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis.

Authors:  Hiroshi Ohira; Takahiro Sato; Osamu Manabe; Noriko Oyama-Manabe; Akiko Hayashishita; Toshitaka Nakaya; Junichi Nakamura; Naoko Suzuki; Ayako Sugimoto; Sho Furuya; Satonori Tsuneta; Taku Watanabe; Ichizo Tsujino; Satoshi Konno
Journal:  ERJ Open Res       Date:  2022-05-09

10.  Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.

Authors:  A J Lopes; S L S Menezes; C M Dias; J F Oliveira; M R M Mainenti; F S Guimarães
Journal:  Braz J Med Biol Res       Date:  2012-02-16       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.